Stay updated on Simufilam 100 mg in Alzheimer's Clinical Trial
Sign up to get notified when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.

Latest updates to the Simufilam 100 mg in Alzheimer's Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPremier Research was added as a collaborator and Premier Research Group plc was removed in the Collaborators section (Revision: v3.3.2).SummaryDifference0.1%

- Check19 days agoChange DetectedRemoved the banner notice about government funding and NIH operating status. The study details and page functionality remain unaffected.SummaryDifference0.2%

- Check34 days agoChange DetectedNo additions or deletions were detected between the two screenshots. Differences appear to be non-substantive formatting or layout changes that do not affect the trial's core details.SummaryDifference0.3%

- Check62 days agoChange DetectedMajor addition of a government funding notice and upgrade to v3.2.0, replacing v3.1.0; references to operating status and status inquiries are now present.SummaryDifference2%

- Check69 days agoChange DetectedUpdated page to v3.1.0; removed several drug-safety topic categories (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and retained the older version tag v3.0.2, suggesting a reorganization of content around a new version.SummaryDifference0.3%

- Check83 days agoChange DetectedThe page now shows Revision: v3.0.2, replacing v3.0.1, signaling a new release. The Back to Top link has been removed, a minor UI change.SummaryDifference0.1%

Stay in the know with updates to Simufilam 100 mg in Alzheimer's Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Simufilam 100 mg in Alzheimer's Clinical Trial page.